Globeflex Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.14M | Buy |
|
|||||
|
2025
Q2 | $3.58M | Buy |
|
|||||
|
2025
Q1 | $2.46M | Sell |
|
|||||
|
2024
Q4 | $3.19M | Buy |
|
|||||
|
2024
Q3 | $2.56M | Buy |
|
|||||
|
2024
Q2 | $2.96M | Sell |
|
|||||
|
2024
Q1 | $3.16M | Hold |
|
|||||
|
2023
Q4 | $3.02M | Buy |
|
|||||
|
2023
Q3 | $2.38M | Hold |
|
|||||
|
2023
Q2 | $1.99M | Sell |
|
|||||
|
2023
Q1 | $2.54M | Buy |
|
|||||
|
2022
Q4 | $2.06M | Buy |
|
|||||
|
2022
Q3 | $1.23M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $542K | Sell |
|
|||||
|
2020
Q2 | $809K | Sell |
|
|||||
|
2020
Q1 | $802K | Hold |
|
|||||
|
2019
Q4 | $996K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $812K | Sell |
|
|||||
|
2015
Q2 | $1.17M | Buy |
|